Category Archives: HIV policy

Help end the HIV, Hep C & STD Epidemics in California

Project Inform is pleased to be one of the key leaders of a critically important and innovative effort to end the HIV, HCV and STD epidemics in California. We have the tools we need to effectively address these epidemics and our coalition of over 85 community…Read More

Rededicating ourselves to fierce advocacy on World AIDS Day 2018

Tomorrow is World AIDS Day, conceived of by two public information officers from the World Health Organization in the 1980s as a day of HIV “awareness and remembrance.” Increasing awareness is important. Our lives count, and when the very existence of those we love and fight…Read More

Administration Proposes Dangerous Access Barriers for HIV Drugs

Reprinted from The AIDS Institute Media Contact:  Carl Schmid: (202) 669-8267 cschmid@theaidsinstitute.org Proposed Medicare Part D Rule Ignores Treatment Protocols Washington, DC – Today, the Trump Administration proposed to add unprecedented access restrictions to lifesaving HIV drugs that, if finalized, will jeopardize our Nation’s efforts to provide treatment to…Read More

RX ALERT: Requirements for furnishing and dispensing drugs during a declared state of emergency

CPhA would like to remind pharmacists about the Board of Pharmacy’s requirements for furnishing prescription drugs in a declared state of emergency. Under Business and Professions Code 4062, a pharmacist may, in good faith, furnish dangerous drugs and devices without a prescription as long as: It’s in…Read More

Seeking your help to end the HIV and hepatitis C epidemics and significantly reduce the incidence of STDs in California!

Project Inform is partnering with HIV, hepatitis and STD organizations from across the state to call on the next Governor of California to develop and implement a statewide plan to end the HIV and hepatitis C epidemics and to significantly reduce the incidence of STDs. We…Read More

IAS2018: PrEP does not lower feminising hormone level in transgender women

Published by and re-posted from aidsmed.com. Tenofovir levels fell slightly, but implications for HIV prevention are unclear Using Truvada (tenofovir DF/emtricitabine) for HIV prevention does not lower levels of feminising hormones, offering reassurance for transgender women who are concerned about drug interactions, according to a presentation…Read More

IAS2018: Bay Area, U.S. & GlobaRights Advocates Demand 2020 International AIDS Conference Be Removed from U.S.

Re-posted from Positive Women’s Network **FOR IMMEDIATE RELEASE** Contact: Cecilia Chung +1.415.902.0216, cecilia@transgenderlawcenter.org Naina Khanna +1.510.681.1169, nkhanna@pwn-usa.org George Ayala +1.213.268.1777, gayala@mpactglobal.org BAY AREA, U.S. AND GLOBAL HUMAN RIGHTS ADVOCATES DEMAND 2020 INTERNATIONAL AIDS CONFERENCE BE REMOVED FROM U.S. They cite danger for potential participants and human…Read More